CUTAQUIG 165mg / ml injectible solution medication leaflet

J06BA01 normal human immunoglobulin • Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human

Normal human immunoglobulin is used for the treatment and prevention of infections in patients with primary or secondary immune deficiencies. It contains antibodies that help strengthen the immune system.

The medication is administered intravenously, as directed by a doctor. The dose and frequency of administration are adjusted based on the patient's condition.

Side effects may include headache, fever, nausea, or injection site reactions. In rare cases, severe allergic reactions or thrombosis may occur.

Normal human immunoglobulin is not recommended for patients with hypersensitivity to human immunoglobulins or severe IgA deficiency.

General data about CUTAQUIG 165mg / ml

Substance: normal human immunoglobulin

Date of last drug list: 01-10-2019

Commercial code: W66182012

Concentration: 165mg / ml

Pharmaceutical form: injectible solution

Quantity: 10

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M.B.H. - AUSTRIA

Holder: OCTAPHARMA (IP) SPRL - BELGIA

Number: 12086/2019/12

Shelf life: 24 months

Pharmaceutical forms available for normal human immunoglobulin

Concentrations available for normal human immunoglobulin

100g/l, 100mg/ml, 165mg/ml, 200mg/ml

Other substances similar to normal human immunoglobulin